2017
CATEGORY
2017.1.26
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations
2017.1.25
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
2017.1.24
Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders
2017.1.23
Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population
2017.1.22
Genetic Variants of RAMP2 and CLR are Associated with Stroke
2017.1.21
Pathogen lineage-based genome-wide association study identified CD53 as susceptible locus in tuberculosis
2017.1.20
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease
2017.1.19
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine
2017.1.18
Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head
2017.1.17
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials
2017.1.16
Genome-wide association study of neovascular age-related macular degeneration in the Thai population
2017.1.15
Genome-wide association study identifies 112 new loci for body mass index in the Japanese population
2017.1.14
A functional variant in MIR4300HG, the host gene of microRNA MIR4300 is associated with progression of adolescent idiopathic scoliosis.
2017.1.13
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
2017.1.12
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
2017.1.11
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion
2017.1.10
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response
2017.1.9
Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis
2017.1.8
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway
2017.1.7
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
2017.1.6
Identification of six new genetic loci associated with atrial fibrillation in the Japanese population
2017.1.5
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation
2017.1.4
Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism
2017.1.3
Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels
2017.1.2
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study
2017.1.1
Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs
2017.1.1
Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
2017.1.1
Statin use and all-cause and cancer mortality: BioBank Japan cohort
2017.1.1
Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan
2017.1.1
Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project
2017.1.1
Overview of the BioBank Japan Project: Study design and profile
2017.1.1
Overview of BioBank Japan follow-up data in 32 diseases
2017.1.1
Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project
2017.1.1
Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases
2017.1.1
Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project
2017.1.1
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
2017.1.1
Characteristics of patients with liver cancer in the BioBank Japan project
2017.1.1
Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project
2017.1.1
Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project
2017.1.1
Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project